ScholarIQanswers from OpenAlex
Community Health Network
InstitutionResearch output, impact & collaborations
Community Health Network is a institution indexed in ScholarIQ from OpenAlex.
What is known about Community Health Network?
ScholarIQrecord summary
Community Health Network is a research organisation in Indianapolis, US. OpenAlex records 505 works and 8,771 citations for it. 263 researchers list it as their most recent affiliation.
How many works does Community Health Network have?
ScholarIQindexed works
Community Health Network has 505 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Community Health Network have?
ScholarIQcitation count
Community Health Network has 8,771 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Community Health Network?
ScholarIQresearcher count
Community Health Network has 263 researchers in the ScholarIQ index.
What is the average h-index at Community Health Network?
ScholarIQavg h-index
Community Health Network has an average h-index of 60 in OpenAlex.
What is the ROR of Community Health Network?
ScholarIQror
The ROR for Community Health Network is on the source record.
What is the OpenAlex record for Community Health Network?
ScholarIQopenalex
The OpenAlex for Community Health Network is on the source record.
Who are the most-cited researchers behind Community Health Network?
ScholarIQtop researchers by citations
What are the most-cited papers on Community Health Network?
ScholarIQmost cited works
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins, Scott Berry, Blasé N. Polite, Eileen M. O’Reilly, Richard M. Goldberg, Howard S. Höchster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter J. Watson, Al B. Benson, Daniel Mulkerin, Robert J. Mayer, Charles D. Blanke
Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas
Howard A. Burris, Herbert I. Hurwitz, Elizabeth Claire Dees, Afshin Dowlati, Kimberly Blackwell, Bert H. O’Neil, P. Kelly Marcom, Matthew J. Ellis, Beth Overmoyer, Suzanne F. Jones, Jennifer L. Harris, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steve Mangum, Neil L. Spector
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
Bert H. O’Neil, John M. Wallmark, David Lorente, Elena Élez, Judith Raimbourg, Carlos Gomez‐Roca, Samuel Ejadi, Sarina A. Piha‐Paul, Mark N. Stein, Albiruni R. Abdul Razak, Katia Dotti, Armando Santoro, Roger B. Cohen, M. Gould, Sanatan Saraf, Karen Stein, Sae‐Won Han
How much of the research on Community Health Network is open access?
ScholarIQopen access share
100%OPEN ACCESS